HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hachida, M. Articles by Morton, D. L. Search for Related Content PubMed PubMed Citation Articles by Hachida, M. Articles by Morton, D. L.

The Annals of Thoracic Surgery, Vol 45, 643-646, Copyright © 1988 by The Society of Thoracic Surgeons

ARTICLES

A comparison of solutions for lung preservation using pulmonary alveolar type II cell viability

M Hachida, DS Hoon and DL Morton
Department of Surgery, UCLA School of Medicine 90024.

Many special solutions have been developed to protect the ischemic lung in preparation for transplantation. To determine an effective solution, we isolated pulmonary alveolar type II cells from rat lungs. These cells play an important role in sodium transport and the production of surfactant; thus, they are crucial to the respiratory physiology of the lung. In this study, we examined in vitro the effect of various solutions such as Collins' solution, Collins-Sacks solution, and glucose-insulin-potassium solution on alveolar type II cell viability. The cell viability was examined with a trypan blue dye exclusion test and [3H]thymidine uptake proliferation assay after 24 and 72 hours of incubation. The alveolar type II cells in the glucose-insulin-potassium solution had greater viability compared with cells cultured in either Collins' or Collins-Sacks solution. This study demonstrates that glucose-insulin-potassium solution has the least toxic effect on isolated alveolar type II cells compared with other preserving solutions.

This article has been cited by other articles:

				Y. Liu, Q. Wang, X. Zhu, D. Liu, S. Pan, Y. Ruan, and Y. Li Pulmonary artery perfusion with protective solution reduces lung injury after cardiopulmonary bypass Ann. Thorac. Surg., May 1, 2000; 69(5): 1402 - 1407. [Abstract] [Full Text] [PDF]

				R. C. King, O. A. R. Binns, R. C. Kanithanon, P. E. Parrino, T. B. Reece, J. D. Maliszewskyj, K. S. Shockey, C. G. Tribble, and I. L. Kron Acellular Low-Potassium Dextran Preserves Pulmonary Function After 48 Hours of Ischemia Ann. Thorac. Surg., September 1, 1997; 64(3): 795 - 800. [Abstract] [Full Text]

				O. A. R. Binns, N. F. DeLima, S. A. Buchanan, J. T. Cope, R. C. King, C. A. Marek, K. S. Shockey, C. G. Tribble, and I. L. Kron BOTH BLOOD AND CRYSTALLOID-BASED EXTRACELLULAR SOLUTIONS ARE SUPERIOR TO INTRACELLULAR SOLUTIONS FOR LUNG PRESERVATION J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1515 - 1521. [Abstract] [Full Text]

				C. J. Serrick, A. Jamjoum, A. Reis, A. Giaid, and H. Shennib AMELIORATION OF PULMONARY ALLOGRAFT INJURY BY ADMINISTERING A SECOND RINSE SOLUTION J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1010 - 1016. [Abstract] [Full Text]

				M. Struber, J. Cremer, W. Harringer, S. W. Hirt, A. Costard-Jackle, and A. Haverich NEBULIZED SYNTHETIC SURFACTANT IN REPERFUSION INJURY AFTER SINGLE LUNG TRANSPLANTATION J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 563 - 564. [Full Text]